1. Department of Health and Human Services:National Heart and Lung Institute Blood Resource Studies. Vol 3:Pilot Study of Hemophilia Treatment in the U.S. U.S. Government Printing Office, Washington, 1972.
2. Biggs R. Jaundice and antibodies directed against Factors VIII and IX in patients treated for haemophilia or Christmas disease in the United Kingdom. British J Haematology26:313, 1974.
3. Sultan Y and French Hemophilia Study Group. Prevalence of inhibitors in a population of 3,435 hemophilia patients in France. Thrombosis and Haemostasis67:600, 1992.
4. Ehrenforth S, Kreuz W, Scharrer I, Linde R, Funk M, Gungor T, Krackhardt B, and Kornhuber B. Incidence of development of Factor VIII and Factor IX inhibitors in haemophiliacs. Lancet339:594, 1992.
5. Ljung R, Petrini P, Iindgren AC, Tengborn, and Nilsson IM. Factor VIII and Factor IX inhibitors in haemophiliacs. Lancet339:1550, 1992.